1 MCIC VTE Prophylaxis All Team Call Sean Berenholtz, MD MHS and VTE Subcommittee 5.23.2006.

Slides:



Advertisements
Similar presentations
Hollie Shaner-McRae DNP RN FAAN
Advertisements

Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.
VTE in abdominal-pelvic surgery patients
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
SUSP Surgeon call February 26, 2014
DVT PROPHYLAXIS SUNDIP PATEL 7 / 15 / BACKGROUND Deep Vein Thrombosis is a common, yet preventable peri-operative complication Highest risk in critical.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment Pamela Hebbard August 11, 2005.
Prophylaxis of Venous Thromboembolism
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Deep Vein Thrombosis (DVT)
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation.
Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2013.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
DVT Prophylaxis in Medical Patients Rog Kyle, MD MUSC 6/5/12.
Post OP Glucose Control For Cardiac Surgery The Society of Thoracic Surgeons Workforce guidelines (Lazar, 2009) recommended cardiac surgery patients, with.
Sean Berenholtz, MD MHS FCCM September 20, 2011 at 2ET/1 CT/12 MT/11 PT Ventilator Associated Pneumonia Prevention CLABSI Supplemental Call Series.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 Surgical Site Infection Tools for Improvement SUSP.
Venous Thromboembolism Safety Tool Kit Brenda K. Zierler, PhD, RN, RVT University of Washington Medication Safety: Tools for Diverse Settings September.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Safety Basic Science December 22 nd, Safety Attitudes Questionnaire (SAQ) I am encouraged by my colleagues to report any patient safety concerns.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
The Cardiac Surgery Translational Study (“CSTS”) The Quality And Safety Research Group Data We Can Count On Lisa H. Lubomski, PhD April 8, 2011 Immersion.
The Surgical Infection Prevention and Surgical Care Improvement Projects National Initiatives to Improve Surgical Care Dale W. Bratzler, DO, MPH QIOSC.
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
Linking Quality Improvement and Infection Prevention Manoj Jain, MD, MPH Medical Director, QSource 19 February, 2009.
The Cardiac Surgery Translational Study (“CSTS”) The Quality And Safety Research Group Ventilator Associated Pneumonia Prevention Sean Berenholtz, MD MHS.
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Making Surgery Safer: Making Surgery Safer: Surgical Infection Prevention Team Members: Anesthesia: W. Scott Jellish – chair, Maureen Kawka Infectious.
Preoperative Management of Hypoxic Patients
Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis.
Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Building Your SUSP Team Part I Armstrong Institute for Patient Safety and Quality.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
Prevention of SSI- Applying the Glucose Control Component Sharing the HHS Experience Dr. Richard McLean, MD, FRCP(C) Emily Christoffersen RN, BScN Rhonda.
DVT Prevention and Anticoagulant Management
Introduction to Core Measures
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Hospital-Acquired VTE: What We Have Learned Martha J. Radford, MD Chief Quality Officer NYU Langone Medical Center September 2009.
Preventing Surgical Infections Through Effective Perioperative Antibiotic Administration Project Team Members: Anesthesia Infectious Disease Pharmacy Surgical.
Prophylaxis Diagnosis Treatment Venous Thromboembolism Management.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
Dabigatran Etexilate is Effective and Safe for the Extended Prevention of Venous Thromboembolism Following Total Hip Replacement Eriksson BI, Dahl OE,
Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Preventing DVT in Hospitalized Patients Bill Cayley MD.
Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Venous Thromboembolism Prophylaxis in Pediatric Patients With Central Venous.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Prevention of Venous Thromboembolism in Nonsurgical Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Checklist overlap: Prevention of Surgical Site Infection and Venous Thromboembolism Marlies van Dijk, Western Node Leader Safer Healthcare Now! Safe Surgery.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Spotlight Case January 2006 An Ounce of Prevention.
Enhanced Recovery After Surgery Alan Willson 17 November 2010
Venous Thromboembolism Prophylaxis (VTE)
Surgical Care Improvement Project (SCIP)
Dr. Richard McLean, MD, FRCP(C) Emily Christoffersen RN, BScN
Western Node Collaborative
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

1 MCIC VTE Prophylaxis All Team Call Sean Berenholtz, MD MHS and VTE Subcommittee

2 MCIC VTE Subcommittee JHH Paula Biscup Lisa Rowen Renee Demski Michael Streiff David Hunt Deborah Hobson URMC Edward Bell Robert Panzer Diane Cockrell Ivelisse Vicente Alan Curle Karen Zinnecker Charles Francis NYP Audrey Compton Joseph Cooke David Diuguid Sue Kim YNHH Nabil Atweh Andrea Benin Veronica Chiang Ann Ertel Charles Watson Kathy Hearn Pamela Cullen Lori Ryder Mary Ellen Ksoturko Keith Ruskin Ena Williams Walter Cholewczynski

3 Safety Measures How often do we harm patients? –Measures of harm (Surgical site infections (SSI)) How often do we do what we should? –Surgical Care Improvement Project (SCIP) process measures, –Venous thromboembolism (VTE) prophylaxis, How often do we learn from defects? –Learn from one per month (National Quality Forum never events, mislabeled specimens) How well do we improve culture? –Safety Attitude Questionnaire (SAQ), –Comprehensive Unit Safety Program (CUSP)

4 Most common preventable cause of hospital death Hirsh DR et al. JAMA 1995;274:335-7 Bick RL Semin Thromb Hemost 1999;25:251-3 Annual Incidence in US

5 Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest Sep;126(3 Suppl):338S-400S

6 Recommendations General surgery –surgical oncology, gynecology, urology, vascular, transplant, thoracic surgery Orthopedics Trauma Neurosurgery

7 Overall Adherence for VTE Prophylaxis at JHHS: Baseline n = 7/8n = 71/219*n = 3/13n = 20/88n = 13/44 * Aggregate DOES NOT INCLUDE GU cases that were contraindicated for pharmacologic interventions n = 12/16n = 12/31n = 3/15n = 1/4

8 SCIP Measures SCIP VTE 1: Surgery patients with recommended VTE prophylaxis ordered SCIP VTE 2: Surgery patients who received appropriate VTE prophylaxis within 24 hours prior to surgery to 24 hours after surgery SCIP VTE 3: Intra- or postoperative PE diagnosed during index hospitalization and within 30 days of surgery (OUTCOME) SCIP VTE 4: Intra- or postoperative DVT diagnosed during index hospitalization and within 30 days of surgery (OUTCOME)

9 Assumptions Data collected in immediate periop period (preop holding area thru time of PACU/ICU admission Concurrent data collection preferred Risk stratification defined by local consensus Evidence of risk stratification includes a completed risk stratification tool, a physician, NP, or PA note documenting that the patient is at risk for VTE Exclusions: < 18 yo, hospital LOS < 24 hours

10 Proposed MCIC VTE Measures General surgery (includes surg onc, urology, vascular and transplant surgery) Trauma Neurosurgery (intracranial, spinal cord injury, elective spine surgery) Bariatric surgery

11 Proposed MCIC VTE Measures Documentation of Risk Stratification –% patients with evidence of risk stratification in chart Prophylaxis for VTE –% patients who have an order written to start prophylaxis during the time period within 24 hrs prior to incision through 24 hrs after surgery end time –% patients who have an order written to start prophylaxis at the recommended dosing during the time period within 24 hrs prior to incision time through 24 hrs after surgery end time

12 Proposed MCIC VTE Measures Contraindications to VTE prophylaxis –% patients with any contraindication to pharmacologic prophylaxis –% patients with contraindication to pharmacologic prophylaxis due to a high risk of bleeding treated with mechanical prophylaxis (GCS or IPC or SCD) % patients included in review process GCS: graduated compression stockings; IPC: intermittent pneumatic compression devices; SCD: sequential compression devices

13 Data Collection Plan Data collection tool developed Pilot testing: June 2006 –Concurrent data collection: convenience sample of 5-10 pts –Retrospective Review: 10 randomly selected patient-charts Implementation: July 2006 –Concurrent data collection: All patients seen by the clinical area improvement team –Retrospective Review: 10 randomly selected patient-charts per month per surgery type Maintenance: >= 90% performance –TBD

14 Reports Single period reports Performance over time Comparison to collaborative Data remains anonymous

15 Change is Local Educate staff –Partner with hematology, Guidelines, Fact sheet, powerpoint slides Reduce complexity –Standardized tool, computerized decision support Create redundancy –Multidisciplinary teams, add to existing checklists, briefings/debriefings Measure performance –Identify when this will occur during the periop period

16 Team Check-up Tool Reviewed data with team Number of team meetings Met with executive Reviewed data with executive Barriers to progress

17 Next Steps Finalize teams Gain consensus on evidence and risk stratification Pilot test data collection tool Conference call to review pilot phase –Burden, revise measures/tools, timeline Live the grid Conference calls for sharing